What’s Psychedelic Integration Mean in Practical Terms?
Going on a psychedelic trip is a lot like...
What’s Psychedelic Science
The last decade has been inarguably incredible...
What’s Psychedelic Medicine?
Psychedelics and entheogens also called...
What’s Plant Medicine
Plant medicines are a healing tool, used by...
Is Cannabis a drug?
Cannabis (Marijuana) is one of the most popular...
What’s Psychedelic Therapy
Psychedelic therapy is a technique that involves...
THC microdosing reduces chronic pain in world-first clinical trial
New research published in the European Journal...
Oregon to officially vote on legalizing psychedelic psilocybin therapy
The state of Oregon will officially vote on legalizing psilocybin psychotherapy in the upcoming November election, after well over 150,000 signatures were collected to secure the landmark ballot measure. The initiative focuses on licensed and regulated psychedelic-assisted psychotherapy in clinical environments.
Psilocybin & OCD: Can psychedelics treat obsessive compulsive disorder?
A new review from neuroethicist Eddie Jacobs, and published in the Journal of Psychedelic Studies, is suggesting psilocybin may have great potential as a treatment for obsessive-compulsive disorder (OCD). Jacobs, from King’s College London and the University of Oxford, says it is surprising how little focus has been on the therapeutic potential of psilocybin in treating OCD, and he points to a number of new clinical trials that are finally exploring this promising treatment.
World-first clinical trial finds CBD can help treat cannabis addiction
Positive results from the world’s first clinical trial testing the potential for cannabidiol (CBD) to treat cannabis addiction suggest daily use of medical-grade CBD is both safe and effective at reducing problematic cannabis consumption.
Canada grants first legal exemptions for psilocybin use in 50 years
After waiting more than 100 days for a response, four terminally ill cancer patients have now been approved to use psilocybin to treat end-of-life distress. These patients will be the first to legally use the psychedelic in Canada for almost half a century following the country’s health minister granting them a unique special exemption.
CBD increases blood flow in regions of the brain linked to memory
A new study, led by researchers from University College London, is offering some of the first robust evidence showing how cannabidiol (CBD), a key compound in cannabis, increases cerebral blood flow in memory processing regions of the brain such as the hippocampus.
Landmark clinical trial exploring LSD-MDMA combo to begin late 2020
Psychedelic pharmaceutical company MindMed is...
LSD microdose trial for acute pain relief reports “remarkable” results
An incredible, first-of-its-kind trial testing...
Cannabis may reduce acute OCD symptoms, but long-term effects unclear
Research from Washington State University (WSU),...
Psilocybin therapy 4 times more effective than antidepressants, study finds
A new study is presenting the first published data from preliminary human trials investigating the effect of psilocybin-assisted psychotherapy to treat major depressive disorder (MDD). The incredibly positive results have been described as just a “taste of things to come” with larger a Phase 2 trial well underway.
US voters embrace landmark drug reform measures in 2020 election
Four states passed new recreational marijuana measures in the 2020 election. Arizona, Montana, New Jersey and South Dakota passed legalization measures introducing laws allowing for recreational use of marijuana. These measures will most likely manifest practically in ways similar to recreational roll-outs of marijuana in other US regions over the past few years. South Dakota and Mississippi both also passed ballot measures legalizing medical marijuana.
How psychedelic DMT promotes the production of new brain cells
Robust new research, published in the...
Psilocybin & migraine: First of its kind trial reports promising results
A first-of-its-kind exploratory study, led by researchers from Yale School of Medicine, has found a single dose of the psychedelic psilocybin can reduce migraine frequency by 50 percent for a least two weeks. The preliminary trial was small, with follow-up work necessary to validate the results, but the promising findings suggest great potential for psychedelics to treat migraines and cluster headaches.
World-first cannabis study finds CBD alone doesn’t impair driving ability
A novel study investigating the effects of cannabis on driving in a real-world context has found cannabidiol (CBD) alone does not impair driving ability. The landmark finding promises to be invaluable in guiding road safety regulations as cannabis laws shift across the globe.
Entheogen-assisted Healing
Taking entheogens can be like air travel: people do it all the time, it’s usually fine, but when it’s not fine, it’s sometimes very bad. We’ve been there. And that’s where an experienced GUIDE can make the difference in the outcome.
I’m available by phone if you or someone you know wants to ask questions of ANY nature. Use this link to schedule a call HERE.